Global X Genomics & Biotechnology ETF
Price through Oct 27, 2026 · Flows through Aug 23, 2024. Figures use the latest available records, not a live quote. Fund details retrieved Oct 27, 2026. Holdings snapshot retrieved Oct 27, 2026.
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
GNOM price
Table
| Date | GNOM close |
|---|---|
| Sep 28, 2026 | $70.30 |
| Sep 29, 2026 | $70.35 |
| Sep 30, 2026 | $70.48 |
| Oct 1, 2026 | $68.78 |
| Oct 2, 2026 | $69.62 |
| Oct 5, 2026 | $72.30 |
| Oct 6, 2026 | $67.60 |
| Oct 7, 2026 | $66.85 |
| Oct 8, 2026 | $65.83 |
| Oct 9, 2026 | $68.75 |
| Oct 12, 2026 | $66.64 |
| Oct 13, 2026 | $65.34 |
| Oct 14, 2026 | $65.91 |
| Oct 15, 2026 | $67.01 |
| Oct 16, 2026 | $64.31 |
| Oct 19, 2026 | $65.58 |
| Oct 20, 2026 | $67.65 |
| Oct 21, 2026 | $68.72 |
| Oct 22, 2026 | $66.01 |
| Oct 23, 2026 | $65.58 |
| Oct 26, 2026 | $66.46 |
| Oct 27, 2026 | $68.80 |
Daily net flows, 1M
Net outflow over the range: −$0M
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Jul 23 | −$115.9K |
| Jul 24 | −$127.3K |
| Jul 25 | $199.2K |
| Jul 26 | −$74K |
| Jul 29 | $95.8K |
| Jul 30 | −$29.1K |
| Jul 31 | −$169K |
| Aug 1 | $48.7K |
| Aug 2 | $162.3K |
| Aug 5 | −$173.1K |
| Aug 6 | $199.2K |
| Aug 7 | −$244.1K |
| Aug 8 | $130.4K |
| Aug 9 | $49K |
| Aug 12 | $748 |
| Aug 13 | −$55.3K |
| Aug 14 | −$10K |
| Aug 15 | $26.2K |
| Aug 16 | $51.9K |
| Aug 19 | −$135.7K |
| Aug 20 | $156.6K |
| Aug 21 | −$139.8K |
| Aug 22 | $103.9K |
| Aug 23 | $0 |
Recent fund-flow records are unavailable, while the price has returned +51.4% so far this year. At 0.50% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | MRNAMODERNA | 11.05% | $207.97 | +4.6% | ||
| 2 | TWSTTWIST BIOSCIENCE | 6.70% | $159.85 | +10.1% | ||
| 3 | TXG10X GENOMICS | 6.38% | $78.02 | +6.9% | ||
| 4 | ILMNILLUMINA | 6.09% | $279.47 | +3.1% | ||
| 5 | GHGUARDANT HEALTH | 5.22% | $178.06 | +2.8% | ||
| 6 | NTRANATERA | 5.50% | $410.82 | +1.5% | ||
| 7 | QGENQIAGEN NV | 3.26% | $50.17 | -0.4% | ||
| 8 | TECHBIO-TECHNE | 3.56% | $72.60 | -0.1% | ||
| 9 | VRTXVERTEX PHARMACEUTICALS | 3.33% | $521.03 | +0.7% | ||
| 10 | CAICaris Life Sciences | 2.68% | $33.67 | +3.7% | ||
| 11 | VCYTVERACYTE | 2.57% | $50.28 | +4.3% | ||
| 12 | BMRNBIOMARIN PHARMACEUTICAL | 2.94% | $55.35 | -0.7% | ||
| 13 | CRSPCRISPR THERAPEUTICS AG | 2.63% | $51.47 | +5.0% | ||
| 14 | CDNACAREDX | 2.17% | $70.53 | +2.1% | ||
| 15 | LEGNLEGEND BIOTECH | 1.97% | $21.56 | +5.7% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 41Sector weights
- Healthcare100%
- Health Technology99.08%
- Health Services0.75%
- Miscellaneous0.15%
- Other0.06%
Show as table
| Item | Value (%) |
|---|---|
| Healthcare | 100% |
| Health Technology | 99.08% |
| Health Services | 0.75% |
| Miscellaneous | 0.15% |
| Other | 0.06% |
Country weights
- United States92.49%
- Hong Kong3.81%
- Germany3.28%
- China3.13%
- Switzerland3.08%
- Japan0.59%
- Netherlands0.55%
- Italy0.11%
Show as table
| Item | Value (%) |
|---|---|
| United States | 92.49% |
| Hong Kong | 3.81% |
| Germany | 3.28% |
| China | 3.13% |
| Switzerland | 3.08% |
| Japan | 0.59% |
| Netherlands | 0.55% |
| Italy | 0.11% |
| 1 week | +0.1% |
| 1 month | -2.0% |
| 3 months | +28.1% |
| 6 months | +49.7% |
| YTD | +51.4% |
| 1 year | +54.5% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | — |
| 1 month | — |
| 3 months | — |
| YTD | — |
| 1 year | — |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
Monthly net flows
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Oct | −$296.6M |
| Nov | −$9.1M |
| Dec | −$19.7M |
| Jan | −$11.8M |
| Feb | −$862 |
| Mar | $42.1M |
| Apr | −$195.2K |
| May | $195.1K |
| Jun | −$182.1K |
| Jul | −$73.9M |
| Aug | $171K |
The top holding is 11.1% of the book; the top ten carry 56%. Spread across 50+ names, it behaves like roughly 23 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| MRNA MODERNA | $52M | $53M |
| LLY ELI LILLY | $24M | $26M |
| NTRA NATERA | $2M | $2M |
| AZN ASTRAZENECA | $1M | $2M |
| GILD GILEAD SCIENCES | $2M | $738,877 |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat GNOM on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW SPDR Portfolio Developed World ex-US ETF | 0.03% | $40.7B | +$609M | -47bp on fee · 481× the assets · +$609M in over the month | Head-to-head |
| BBUS JPMorgan BetaBuilders U.S. Equity ETF | 0.02% | $9.6B | +$187M | -48bp on fee · 113× the assets · +$187M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -47bp on fee · 217× the assets · +$199M in over the month | Head-to-head |
| SPYG State Street SPDR Portfolio S&P 500 Growth ETF | 0.04% | $57.9B | +$717M | -46bp on fee · 683× the assets · +$717M in over the month | Head-to-head |
| SPTM State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF | 0.03% | $14.2B | +$235M | -47bp on fee · 168× the assets · +$235M in over the month | Head-to-head |